• Access code

    To access the full version of the program with abstracts from presenters and the attendees' list, please enter the code provided and click "submit"
    (for registered delegates only)!
    Enter access code

  • Detailed Program

  • You can use the "Topic" filter and the search engine to narrow your program research.
    The search engine will allow you to find speakers, authors, session titles, abstract titles...
     
    10:15 - 11:00 | Metastasis initiating cells and ecosystems
    person_pin
    Joan MASSAGUE - Memorial SLoan Kettering Cancer Center, United States
    11:00 - 11:30 | Single-cell profiling of the tumor microenvironment during checkpoint immunotherap
    person_pin
    Dieter LAMBRECHTS - VIB Center for Cancer Biology and University of Leuven, Belgium
    11:30 - 11:45 | Unraveling the role of ARID2 in a mouse model of lung adenocarcinoma
    person_pin
    David MARTÍN-GUTIÉRREZ - Instituto de Biomedicina y Biotecnología de Cantabria, Universidad de Cantabria, Spain
    11:45 - 12:15 | A crosstalk between tumor cell plasticity and tumor-associated macrophages shapes immunotherapy response in melanoma
    person_pin
    Félix PHAM - Cancer Research Center of Lyon, France - Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon 1 University, France
    12:15 - 12:18 | scRNASeq analysis of resistance to in situ (immuno)targeted therapies in multiple myeloma reveals the involvement of the IFN (type I and II), p53 and NFkB pathways
    person_pin
    Catherine PELLAT-DECEUNYNCK - Nantes Université, INSERM, CHU Nantes, CNRS, Université d'Angers, CRCI2NA, France - SIRIC ILIAD, France
    12:18 - 12:21 | CROSSTALK BETWEEN PROSTATIC EPITHELIAL CELLS AND THE TUMOR MICROENVIRONMENT DRIVES CANCER PROGRESSION AND METASTASIS.
    person_pin
    Darya YANUSHKO - IGBMC/Université de Strasbourg, France
    12:21 - 12:24 | Microenvironmental niches are associated with distinct evolutionary trajectories in lung neuroendocrine tumors
    person_pin
    Alexandra SEXTON-OATES - International Agency for Research on Cancer, France
    12:24 - 12:27 | The epigenetic regulator TRIM24 controls melanoma cell dedifferentiation promoting invasiveness and resistance to treatment.
    person_pin
    Simon DURAND - Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, France
    12:27 - 12:30 | IN VIVO GENETIC SCREEN MAPS CELL-SURFACE REGULATORS OF MELANOMA DISSEMINATION
    person_pin
    Serena DIAZZI - Centre de Recherche en Cancérologie de Lyon, France
    12:30 - 12:33 | Loss of IRF5 increases ribosome biogenesis leading to alterations in mammary gland architecture and metastasis
    person_pin
    Betsy BARNES - The Feinstein Institutes for Medical Research, United States
    14:30 - 15:00 | SKIN STEM CELLS: COPING WITH INFLAMMATION AND ONCOGENIC STRESS AND RETAINING MEMORIES OF THEIR ENCOUNTERS
    person_pin
    Elaine FUCHS - Howard Hughes Medical Institute, The Rockefeller University, United States
    15:00 - 15:15 | The role of tissue ecology in the metastasis of Estrogen receptor-positive breast cancers.
    person_pin
    Lise MANGIANTE - Stanford Cancer Institute, Stanford University School of Medicine, United States
    15:15 - 15:45 | Tumor Cell Plasticity in Colorectal Cancer
    person_pin
    Frederic DE SAUVAGE - Genentech Inc., United States
    16:45 - 17:15 | Neuroblastoma and the nervous microenvironment: partners-in-crime
    person_pin
    Céline DELLOYE-BOURGEOIS - Cancer Research Center of Lyon - UMR INSERM 1052 - CNRS 5286 - UCBL1, France
    17:15 - 17:30 | Netrin-1 impact colorectal cancer stem cell self-renewal and apoptosis through UNC5B-TFF3 axis
    person_pin
    Morgan BRISSET - Victorian Comprehensive Cancer Centre, The University of Melbourne, Australia - Centre for Cancer Research, The University of Melbourne, Australia
    17:30 - 18:00 | Biomechanical adaptations in metastatic cancer cells
    person_pin
    Victoria SANZ-MORENO - The Institute of Breast Cancer Research, United Kingdom
    08:30 - 09:00 | Understanding why liver metastases are so hard to treat with immunotherapy
    person_pin
    Erik SAHAI - Francis Crick Institute, United Kingdom
    09:00 - 09:15 | Deciphering triple negative breast cancer aggressive populations and their microenvironment
    person_pin
    Eloïse GRASSET - CRCI2NA INSERM U1307, CNRS U6075, Nantes University, Angers University, France
    09:15 - 09:45 | Atypical contribution of caspase-3 to melanoma cancer cell motility by regulating coronin-1B activity
    person_pin
    Gabriel ICHIM - INSERM - CRCL, France
    09:45 - 10:00 | Peripheral positioning of lysosomes supports melanoma aggressiveness
    person_pin
    Katerina JERABKOVA-RODA - INSERM U1109: CRBS Institute, France - Institut Curie, PSL, CNRS, UMR144, France
    10:30 - 11:00 | Intra- and inter-tumoral heterogeneity in small-cell lung cancer progression and metastasis
    person_pin
    Julien SAGE - Stanford University, United States
    11:00 - 11:15 | Epigenetic Regulation of Chromosomal Instability in Triple-Negative Breast Cancer Metastasis
    person_pin
    Yang BAI - Weill Cornell Medicine, United States
    11:15 - 11:45 | Craters on the melanoma surface serve as hubs for CD8+ T cells
    person_pin
    Leonard ZON - Boston Children’s Hospital, Harvard Medical School, United States
    11:45 - 11:48 | EARLY MAMMARY ONCOGENIC STRESS ELICITS UPR-DRIVEN IMMUNOGENICITY SENSED BY NEUTROPHILS
    person_pin
    Antoine DEBIESSE - Centre de Recherche en Cancérologie de Lyon (CRCL), Centre Léon Bérard, Université de Lyon, France
    11:48 - 11:51 | Role of the BMP4/BMPR1A/BRCA1 axis in mammary stem cell transformation and basal-like breast cancer
    person_pin
    Simon AHO - Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, U1052 UMR5286, France
    11:51 - 11:54 | STUDY OF THE MECHANISMS OF OCCURENCE AND EVOLUTION OF EARLY EPITHELIAL TUMOR. IMPLICATIONS FOR PROSTATE CARCINOGENESIS.
    person_pin
    Elissa BAABDATY - IGreD, France
    11:54 - 11:57 | NF-kB2: A Key Regulator of CD8+ T Cell Anti-Tumor Activity
    person_pin
    Khaled BOUHERROU - CRCL - INSERM U1052, France
    11:57 - 12:00 | NEUTROPHILS PROMOTE AGE-INDUCED METASTASIS
    person_pin
    Cristina LIBONI - Tumor Biomechanics Lab, France - INSERM UMR_S1109, France - Université de Strasbourg, France - Fédération de Médecine Translationnelle de Strasbourg (FMTS), France - Equipe Labellisée Ligue Contre le Cancer, France
    12:00 - 12:03 | INNOVATIVE IMMUNOTHERAPIES BASED ON RADIOFREQUENCY AND IMMUNOGEL FOR LOCAL IMMUNE RESPONSE ACTIVATION IN COLORECTAL CANCER.
    person_pin
    Sarah DIAKHABY - Université Paris Cité, CNRS, INSERM, UTCBS, France
    14:45 - 15:15 | Visualizing the benign to malignant switch
    person_pin
    Scott LOWE - MSKCC/HHMI, United States
    15:15 - 15:30 | DNA methylation protects cancer cells against senescence
    person_pin
    Xiaoying CHEN - Université Paris Cité, CNRS, Epigenetics and Cell Fate, France
    15:30 - 16:00 | MYC shapes ER-mitochondria calcium transfer by directly targeting ITPR1: implications for MYC-induced safeguard mechanisms and cancer
    person_pin
    David BERNARD - CRCL, France
    16:00 - 16:15 | NEW INSIGHTS INTO PROSTATE CANCER PROGRESSION AND TREATMENTS
    person_pin
    Daniel METZGER - IGBMC, France - University of Strasbourg, France
    16:45 - 17:15 | Christina CURTIS - Stanford University, USA
    17:15 - 17:30 | DECIPHERING NETRIN-1 IMPLICATION IN SYNOVIAL SARCOMA
    person_pin
    Nicolas BRAISSAND - Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, France - Victorian Comprehensive Cancer Centre, The University of Melbourne, Australia
    17:30 - 18:00 | Cellular Senescence in Aging and Cancer: Insights into Its Relationship with Microorganisms
    person_pin
    Eiji HARA - Research Institute for Microbial Diseases, Osaka University, Japan - Immunology Frontier Research Center, Osaka University, Japan
    09:00 - 09:30 | Elisabeth DE VRIES - University Medical Center, Netherlands - Molecular imaging of checkpoints and immune cells
    09:30 - 10:00 | Can effector T lymphocytes initiate cancer?
    person_pin
    Julien MARIE - Cancer Research Center of Lyon, France
    10:00 - 10:15 | INHIBITION OF THE DNA DAMAGE RESPONSE ENHANCES NATURAL KILLER CELL-MEDIATED CYTOTOXICITY AGAINST COLORECTAL LIVER METASTASIS ORGANOIDS
    person_pin
    Robin WAGNER - Victorian Comprehensive Cancer Centre, The University of Melbourne, Australia - Murdoch Children’s Research Institute, The Royal Children’s Hospital, Australia
    10:15 - 10:45 | Unraveling Myeloid cell Diversity in Cancer
    person_pin
    Leila AKKARI - Netherlands cancer institute. Oncode Institute, Netherlands
    10:45 - 11:00 | Perceive the dynamics of the neutrophil interactome throughout human colorectal tumorigenesis?
    person_pin
    Baptiste MARTINON - Centre de recherche en cancérologie de Lyon, France
    11:30 - 11:45 | NON-CANONICAL TRANSLATION OF ONCOGENES IN CANCER CELLS GENERATES SHARED AND IMMUNOGENIC NEOEPITOPES THAT REPRESENT A NEW FAMILY OF TARGETS FOR CANCER IMMUNOTHERAPY
    person_pin
    Estelle BAULU - Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, France
    11:45 - 12:15 | Cyclic dinucleotide-mediate innate immunity: Basic mechanisms & translational implications
    person_pin
    Andrea ABLASSER - Ecole Polytechnique Fédérale de Lausanne, Switzerland
    12:15 - 13:00 | Stress and inflammation induce a cancer cell stemness pathway leading to tumor initiation and progression
    person_pin
    David CHERESH - University of California San Diego, United States
    001 | TUMOR-STROMA RATIO IN HEAD AND NECK CANCER
    topicTopic: Tumor microenvironment
    person_pin
    Alhadi ALMANGUSH - Department of Pathology, University of Helsinki, P.O. Box 21, FI-00014 Helsinki, Finland, Finland - Institute of Biomedicine, Pathology, University of Turku, Turku, Finland, Finland - Faculty of Dentistry, Misurata University, Misurata, Libya., Libya
    002 | Ribosomal protein L21 (eL21) as a novel externalized protein in cancer cells and a potential target for treatment of triple negative breast cancer
    Lucie Arnould1, Jean-Jacques Diaz1, Marie Alexandra Albaret1, Frédéric Catez1
    topicTopic: Tumor microenvironment
    person_pin
    Lucie ARNOULD - CRCL, France
    003 | Impact of Intestinal Microbiota Dysbiosis in Tumor Microenvironment of Colorectal: Cancer Association between Megasphaera cerevisiae and IL-22 expression
    topicTopic: Tumor microenvironment
    person_pin
    Wafa BABAY - Laboratory of microorganisms and actives biomolecules, Faculty of sciences, University el Manar, , Tunisia
    004 | Regulation by cancer associated fibroblasts of stromal dissemination of breast cancer
    topicTopic: Tumor microenvironment
    person_pin
    Mallar BANERJEE - Dept. of Developmental Bioogy and Genetics, Indian Institute of Science (IISC), India
    005 | Characterization of a TrkC/sortilin/Connexin 43 complex in tumor plasma cells: role in multiple myeloma progression and identification of new therapeutic molecules.
    topicTopic: Tumor microenvironment
    person_pin
    Julien BARTHELEMY - CoMeT Laboratory - UR 24344, University of Poitiers, France - Department of Biochemistry and Molecular Biology, Eurofins, Discovery, Eurofins Cerep, France
    006 | Integrating 3D Tumor Models and Hydrogel-based Microfluidics for Metabolic Contro
    topicTopic: Tumor microenvironment
    person_pin
    Estelle BASTIEN - UCBL-CRCL-ILM, France
    007 | Optimization of precise CRISPR editing in leukemic microenvironment-associated cell lines
    topicTopic: Tumor microenvironment
    person_pin
    Jamie BEAULIEU - Université de Montréal, Canada - Institut de Recherche en Immunologie et Cancérologie (IRIC), Canada
    008 | Deciphering the crosstalk between Subepithelial fibroblasts and cancer cells in human lung cancer
    topicTopic: Tumor microenvironment
    person_pin
    Anne-Laure BEGUE - Institut Curie, France
    009 | CHARACTERISATION OF THE CROSS-TALK BETWEEN PROKINETICIN2 AND RAGE PROTEIN TO CONTROL OVARIAN CANCER DEVELOPMENT
    topicTopic: Tumor microenvironment
    person_pin
    Mélanie BOUDAUD - Commissariat à l’Energie Atomique (CEA), France - UMR 1292 INSERM/CEA/UGA, Team Mechanism of Angiogenesis in Biological Barriers (MAB2), Biology and Biotechnology for Health Laboratory (IRIG), France - Reproductive Biology and Gynaecological Oncology (RBGO), Swansea University Medical School, United Kingdom
    010 | Impact of neuroblastoma-invaded bone marrow mesenchymal stromal cells on hematopoietic stem cells
    topicTopic: Tumor microenvironment
    person_pin
    Sophia BOUNAUD - Cancer Research Center of Lyon (CRCL), CNRS UMR5286, INSERM U1052, Lyon 1 university, Léon Berard Center, France
    011 | Characterizing the modalities of Neuro-Neuroblastoma Crosstalk and Their Role in Tumor Progression
    topicTopic: Tumor microenvironment
    person_pin
    Barbara BRAZ - KidsCaN Team: Cancer Neuroscience and Metastasis in Paediatric Malignancies, Lyon Cancer Research Center, Inserm U1052, 69008 Lyon, France, France
    012 | 3D BIOPRINTED MODELS FOR THE EVALUATION OF ANTITUMOR THERAPIES
    topicTopic: Tumor microenvironment
    person_pin
    Aurélie CADIOU - Université Claude Bernard Lyon 1, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon (CRCL), INSERM 1052, CNRS 5286, Equipe Oncopharmacologie, France - Antineo, France
    013 | BMP4 AND TGFB2 COOPERATIVE SIGNALING THROUGH BMPR1 DRIVE A COL17A1-DEPENDENT CANCER CELL DORMANCY PROGRAM
    topicTopic: Tumor microenvironment
    person_pin
    Laura CASTRO DIAS - Centre de Recherche en Cancérologie de Lyon- CNRS UMR5286, Inserm U1052, France - Université Claude Bernard Lyon 1, CRCL, France
    014 | 5FU induces tumor plasticity through an unexpected translational control mechanism
    topicTopic: Tumor microenvironment
    person_pin
    Mounira CHALABI - CRCL, France
    015 | 3D MULTICELLULAR CANCER MICROENVIRONMENT PLATFORM FOR PERSONALIZED DRUG SCREENING - NEUROBLASTOMA (NB) AS AN EXAMPLE
    topicTopic: Tumor microenvironment
    person_pin
    Hoi Lam CHEUNG - School of Biomedical Science, Institute of Tissue Engineering and Regenerative Medicine and Department of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong - Tissue Engineering Laboratory, Department of Mechanical Engineering, The University of Hong Kong, Hong Kong - Advanced Biomedical Instrumentation Centre, Hong Kong Science Park, Hong Kong
    016 | NSCLC-derived CAFs targeting by a novel RNA aptamer-based strategy
    topicTopic: Tumor microenvironment
    person_pin
    Fabiola CENNAMO - Institute Experimental Endocrinology and Oncology "Gaetano Salvatore" (IEOS), National Research Council (CNR), Italy
    017 | Agarose-based microwells for in-depth understanding of the interplay between metabolism state, overall growth dynamics, and in-situ cell state within 3D Colorectal tumour spheroid models.
    topicTopic: Tumor microenvironment
    person_pin
    Juliette CODEVELLE - UCBL - ILM, France
    018 | Measuring cell activities to quantify phenotypic diversity in breast cancer subtypes using single-cell data
    topicTopic: Tumor microenvironment
    person_pin
    Angele COUTANT - Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, France
    019 | ROLE OF CANCER-ASSOCIATED FIBROBLASTS IN SHAPING THE TUMOR MICROENVIRONMENT IN ORAL SQUAMOUS CELL CARCINOMA
    topicTopic: Tumor microenvironment
    person_pin
    Imane EL HERCH - Cancer Research Center of Lyon , France - Univ Lyon, Claude Bernard Lyon 1 University, France - Centre Léon Bérard, France
    020 | EDUCATION OF TUMOR MICROENVIRONMENT CELLS BY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) B CELLS
    topicTopic: Tumor microenvironment
    person_pin
    Jordan FERREIRA - INSERM - U978, France - Université Sorbonne Paris Nord, France
    021 | DECIPHERING THE MICROENVIRONMENT'S ROLE IN PITUITARY TUMORIGENESIS THROUGH THE USE OF MOUSE MODELS
    topicTopic: Tumor microenvironment
    person_pin
    Alvaro FLORES-MARTINEZ - Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Lyon 1 University, France
    022 | USING A SCALABLE AND STANDARDIZED 3D HUMAN BONE MARROW MODEL TO STUDY THE INTERPLAY BETWEEN HEMATOLOGICAL, IMMUNE AND STROMAL COMPARTMENTS
    topicTopic: Tumor microenvironment
    person_pin
    Mariette GIANNINI - Centre de Recherche en Cancérologie de Lyon (CRCL) - UMR INSERM 1052 CNRS 5286 - Centre Léon Bérard - Université Claude Bernard Lyon 1, France
    023 | Emerging role of proline and αKG metabolism in the control of pyroptosis and hypoxia in triple-negative breast cancers
    topicTopic: Tumor microenvironment
    person_pin
    Emma HENRY - IRCM, Univ Montpellier, ICM, INSERM, France
    024 | Expression Pattern of WNT5A in Gastric Tissue-Associated Fibroblasts and M2 Macrophages Polarized from THP-1 Cells
    topicTopic: Tumor microenvironment
    person_pin
    Wenjun HU - Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Germany
    025 | "Innovative Non-Invasive Approach for Basal Cell Carcinoma: Clinical Outcomes of High-Intensity Focused Ultrasound (HIFU) Treatment"
    topicTopic: Tumor microenvironment
    person_pin
    Katarzyna KLOCEK - Medical University of Wroclaw, Poland
    026 | BTC, A ‘BIOLOGICAL TISSUE COLLECTION’ OF PRE-CLINICAL MODELS FOR BIOMEDICAL RESEARCH
    topicTopic: Tumor microenvironment
    person_pin
    Matthieu LACROIX - Institut de Recherche en Cancérologie de Montpellier (IRCM) - Inserm 1194 - Univ. Montpellier - Institut régional du Cancer de Montpellier, France - RHEM, Réseau d'Histologie Expérimentale de Montpellier, Univ. Montpellier, BioCampus, CNRS, INSERM, France
    027 | Digital Spatial Profiling Identifies Microenvironment Subtypes in Pancreatic Neuroendocrine Tumors and Predicts Postoperative Survival
    topicTopic: Tumor microenvironment
    person_pin
    Fanlu LI - Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China - Research Institute of Pancreatic Diseases, Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai Jiao Tong University School of Medicine, Shanghai, China., China - State Key Laboratory of Systems Medicine for Cancer, Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, China., China
    028 | Combining radiotherapy with JAK inhibitors as a novel therapeutic strategy for rectal cancer
    topicTopic: Tumor microenvironment
    person_pin
    Guang-Yu LIAN - Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom
    029 | INFERENCE AND ANALYSIS OF ECOLOGICAL NETWORKS FOR COMPLEX TUMOR-MICROENVIRONNEMENT SYSTEMS.
    topicTopic: Tumor microenvironment
    person_pin
    Yuliya LIM - International Agency for Research on Cancer, France
    030 | Draxin: A Novel Target for Cancer Therapy
    topicTopic: Tumor microenvironment
    person_pin
    Fabien LUIGGI - Apoptosis, Cancer and Development Laboratory, Centre de Recherche en Cancérologie de Lyon, France
    031 | MPM TUMORS FACE A SELECTION TRADE-OFF BETWEEN 3 DIFFERENT CELLULAR PROFILES
    topicTopic: Tumor microenvironment
    person_pin
    Laurane MANGÉ - Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, France
    032 | Discovery of a bivalent CK2ɑ inhibitor for the treatment of solid tumors
    topicTopic: Tumor microenvironment
    person_pin
    Léna MARLHOUX - Centre de Recherche en Cancérologie de Lyon , France - Kairos Discovery, France
    033 | ​Evaluation of cancer cells mechanical phenotype associated with the resistance to treatment in myeloid leukemia
    topicTopic: Tumor microenvironment
    person_pin
    Camila MARTIN CARDOZO - Univ Lyon, CNRS, INSA Lyon, Ecole Centrale de Lyon, Université Claude Bernard Lyon 1, CPE Lyon, INL, UMR5270, France - Cancer Research Center of Lyon, Inserm U1052, CNRS UMR5286, University of Lyon, France
    034 | Spatial multi-omics analysis of the tumor microenvironment utilizing high-plex HCR Gold RNA-FISH and high-resolution immunofluorescence
    topicTopic: Tumor microenvironment
    person_pin
    Thibaud METZGER - Bruker Spatial Biology, United States
    035 | Telocyte: a new player in the regression of tumor vasculature? Example of infantile hemangioma.
    topicTopic: Tumor microenvironment
    person_pin
    Léa PECHTIMALDJIAN - Bordeaux Institute of Oncology (BRIC), France
    036 | scRNASeq analysis of resistance to in situ (immuno)targeted therapies in multiple myeloma reveals the involvement of the IFN (type I and II), p53 and NFkB pathways
    topicTopic: Tumor microenvironment
    person_pin
    Catherine PELLAT-DECEUNYNCK - Nantes Université, INSERM, CHU Nantes, CNRS, Université d'Angers, CRCI2NA, France - SIRIC ILIAD, France
    037 | CASSIOPEIA: EXPLORING THE TUMOR MICROENVIRONMENT FROM BASIC SCIENCE TO NEW CLINICAL AVENUES IN TRIPLE-NEGATIF BREAST CANCER PATIENTS
    topicTopic: Tumor microenvironment
    person_pin
    Agathe PELTIER - Institut Curie, Stress and Cancer Laboratory, Inserm, U830, Équipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, France
    038 | AN EMBRYONIC MODEL OF NEUROBLASTOMA REVEALS INTERACTIONS BETWEEN EARLY WAVES OF MACROPHAGES AND MALIGNANT CELLS
    topicTopic: Tumor microenvironment
    person_pin
    Audrey PRUNET - MeLiS, Université Claude Bernard Lyon1, CNRS 5284, INSERM 1314, 8 avenue Rockefeller, France
    039 | Impact of DDR1 on clear cell Renal Cell Carcinoma development and metastasis
    topicTopic: Tumor microenvironment
    person_pin
    Chloé REDOUTÉ-TIMONNIER - Team MIRCADE, Univ. Bordeaux, INSERM, BRIC, U1312, France
    040 | Nucount : aggregating nuclei segmentation methods to quantify cell counts in spatial transcriptomics data
    topicTopic: Tumor microenvironment
    person_pin
    Benoit SAMSON - CRCL, France - ENS, France
    041 | scRNAseq ANALYSIS ON PATIENT PRIMARY SAMPLES SUGGESTS A ROLE OF INFLAMMATORY SIGNALING IN RESISTANCE TO NEOADJUVANT CHEMOTHERAPY IN TNBC
    topicTopic: Tumor microenvironment
    person_pin
    Natalia SÁNCHEZ-COLLANTES - Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria-CSIC,, Spain
    042 | PYRUVATE-MEDIATED MODULATION OF PRIMARY CILIA IN COLONIC FIBROBLASTS
    topicTopic: Tumor microenvironment
    person_pin
    Maya SARIEDDINE - IGMM, Univ Montpellier, CNRS, France
    043 | Microenvironmental niches are associated with distinct evolutionary trajectories in lung neuroendocrine tumors
    topicTopic: Tumor microenvironment
    person_pin
    Alexandra SEXTON-OATES - International Agency for Research on Cancer, France
    044 | Lineage of origin-specific developmental programs drive the behaviors of malignant cells in an avian embryo model of human MB subgroups
    topicTopic: Tumor microenvironment
    person_pin
    Servane TAUSZIG-DELAMASURE - MeLiS - Institut NeuroMyoGène Institut NeuroMyoGène – MeLis – UCBL – CNRS UMR5284 – INSERMU1314- Faculté de Médecine et de Pharmacie, Lyon, France. , France
    045 | Innovative preclinical models: Synergizing AVI-PDX and patient-derived organoid technologies for accelerating precision medicine in oncology and immuno-oncology
    topicTopic: Tumor microenvironment
    person_pin
    Romain TEINTURIER - ONCOFACTORY (ERBC), France
    046 | DEVELOPMENT OF A BIOMIMETIC HIGH THROUGHPUT ESSAY TO STUDY NEUROBLASTOMA CELL PROLIFERATION AND DIFFERENTIATION
    topicTopic: Tumor microenvironment
    person_pin
    Nathan THIBIEROZ - Université Grenoble Alpes, CEA, INSERM U1292 Biosanté, CNRS EMR 5000 BRM, France
    047 | CHEMOATTRACTION OF CENTRAL NERVOUS SYSTEM NEURAL PROGENITORS TOWARD THE PANCREATIC CANCER MICROENVIRONMENT
    topicTopic: Tumor microenvironment
    person_pin
    Ha Anh TRAN - Univ. Grenoble Alpes, CEA, Inserm, IRIG, UA13 BGE, Biomics, 38000 Grenoble, France , France
    048 | UNDERSTANDING THE ROLE OF THE IMMUNE MICROENVIRONMENT IN ADRENOCORTICAL CARCINOMA TUMOR PROGRESSION: FIRST STEP TOWARDS DEVELOPMENT OF EFFECTIVE IMMUNOTHERAPY?
    topicTopic: Tumor microenvironment
    person_pin
    Allison VOISIN - iGReD, France
    049 | Cancer Neutrophil Encyclopedia: A Deep Dive into Antigen-Presenting Warriors
    topicTopic: Tumor microenvironment
    person_pin
    Yingcheng WU - Fudan University, China
    050 | CROSSTALK BETWEEN PROSTATIC EPITHELIAL CELLS AND THE TUMOR MICROENVIRONMENT DRIVES CANCER PROGRESSION AND METASTASIS.
    topicTopic: Tumor microenvironment
    person_pin
    Darya YANUSHKO - IGBMC/Université de Strasbourg, France
    053 | Detection of BRCA1 et BRCA2 alterations in circulating tumoral DNA: One year of expertise
    topicTopic: Metastasis and invasion
    person_pin
    Valéry ATTIGNON - Cancer Genomic Platform, Department of Research and Innovation of Leon Berard Comprehensive Cancer Center, Lyon Cancer Research Center - UMR INSERM 1052 / CNRS 5286 / UCBL1, Centre Léon Berard, France, France
    054 | Netrin-1 blockade triggers tumor cell death through UNC5B- and ubiquitin-dependant Mcl-1 decrease
    topicTopic: Metastasis and invasion
    person_pin
    Lia BARCONS - Apoptosis, Cancer and Development Laboratory - Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Institut Convergence PLAsCAN, Centre de Recherche en Cancérologie de Lyon (CRCL), INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon1, , France
    055 | O-glycosylation drives liver cancer growth and reveals a new surface target for therapeutic intervention
    topicTopic: Metastasis and invasion
    person_pin
    Frederic BARD - CRCM, France
    056 | Loss of IRF5 increases ribosome biogenesis leading to alterations in mammary gland architecture and metastasis
    topicTopic: Metastasis and invasion
    person_pin
    Betsy BARNES - The Feinstein Institutes for Medical Research, United States
    057 |
    UNDERSTANDING THE BIOLOGY OF NRG1 FUSION POSITIVE CANCERS TO OVERCOME THE RESISTANCE TO TARGETED THERAPIES
    topicTopic: Metastasis and invasion
    person_pin
    Manon BARRE - Oncopharmacology Lab, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, France
    058 | ZFP36L1-MEDIATED REGULATION OF CELLULAR PRION PROTEIN EXPRESSION IN CMS4 COLORECTAL CANCER
    topicTopic: Metastasis and invasion
    person_pin
    Marie BERNELIN - Centre de recherche des cordeliers, INSERM, Université Paris Cité, Sorbonne Université, France
    059 | Use of organoid models to study invasive cell states in Diffuse Intrinsic Pontine Glioma
    topicTopic: Metastasis and invasion
    person_pin
    Clément BERTHELOT - CRCL, France
    060 | Atypical contribution of caspase-3 to melanoma cancer cell motility by regulating coronin-1B activity
    topicTopic: Metastasis and invasion
    person_pin
    Kévin BERTHENET - Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS 5286,, France - Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université Claude Bernard Lyon 1,, France
    061 | Targeting glucocorticoid receptor signaling in paclitaxel resistance in triple-negative breast cancer
    topicTopic: Metastasis and invasion
    person_pin
    Zélie BOUVERET - CRCL, France
    062 | Embryonic mechanisms of metastatic seeding and disease persistence in aggressive neuroblastoma
    topicTopic: Metastasis and invasion
    person_pin
    Camila CASTILLO FERRER - Centre de Recherche en Cancérologie de Lyon (CRCL), France
    063 | Cell-Cell Adhesion Disruption Drives Stress Granule Formation as a Survival Mechanism in Inflammatory Breast Cancer
    topicTopic: Metastasis and invasion
    person_pin
    Maria Miguel CASTRO - i3S - Institute for Research and Innovation in Health, Portugal - FMUP- Faculty of Medicine University of Porto, Portugal - CI-IPO - IPO Porto Research Center , Portugal
    064 | Inhibition of rRNA maturation in triple negative breast cance
    topicTopic: Metastasis and invasion
    person_pin
    Frédéric CATEZ - Cancer Research Center of Lyon, France
    065 | Activating PIK3CA mutations promote resistance to BRAF-targeted therapies and shape the transcriptomic landscape of BRAF V600E mutant non-small cell lung cancer cells.
    topicTopic: Metastasis and invasion
    person_pin
    Camille CHARRONDIÈRE - CASTING - Cancer dynamics, adaptation and modeling, Inria, Inserm, Ecole Normale Supérieure de Lyon, Centre Léon Bérard, Cnrs, Université Claude Bernard Lyon 1, France - Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, 69008, France, France
    066 | IN VIVO GENETIC SCREEN MAPS CELL-SURFACE REGULATORS OF MELANOMA DISSEMINATION
    topicTopic: Metastasis and invasion
    person_pin
    Serena DIAZZI - Centre de Recherche en Cancérologie de Lyon, France
    067 | LUNG ADENOCARCINOMA PLEURAL METASTASES SHARE SIMILAR MOLECULAR PROFILE WITH BIPHASIC AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA
    topicTopic: Metastasis and invasion
    person_pin
    Gabrielle DREVET - Computational Cancer Genomics team, Genomic Epidemiology branch, International Agency for Research on Cancer/World Health Organization (IARC), Lyon, France, France - Thoracic surgery department, Hopital Louis Pradel, Hospices Civils de Lyon, France - EA 3738 CICLY, Université Claude Bernard Lyon 1, France
    068 | NEWLY EMERGING STRATEGIES IN ANTICANCER DRUG DISCOVERY: DESIGN AND SYNTHESIS OF PROTACS TARGETING PROTEIN KINASE CK2.
    topicTopic: Metastasis and invasion
    person_pin
    Marthe DUBOST - Université Claude Bernard Lyon 1, France - Centre de Recherche En Cancérologie (CRCL), France - INSERM 1052, France - CNRS 5286, France - Centre Léon Bérard, Team Small Molecules for Biological Targets, France
    069 | The epigenetic regulator TRIM24 controls melanoma cell dedifferentiation promoting invasiveness and resistance to treatment.
    topicTopic: Metastasis and invasion
    person_pin
    Simon DURAND - Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, France
    070 | Dual Role of Nucleolin in Colorectal Cancer progression: Implications for Cell Cycle regulation, Genomic stability, and Senescence
    topicTopic: Metastasis and invasion
    person_pin
    Laura DURANTON - Centre de Recherche en Cancérologie de Lyon (CRCL), France
    071 | Searching for Tumor-Specific Matrisome Markers in Endometrial Cancer: a role for Annexins in tumor growth and metastasis ?
    topicTopic: Metastasis and invasion
    person_pin
    Laurent FATTET - CRCL, France
    072 | Identification and characterisation of snoRNAs as circulating biomarkers of bone recurrence in breast cancer
    topicTopic: Metastasis and invasion
    person_pin
    Charlotte FILOSSI - Ribosome, Translation and Cancer team, LabEx DEVweCAN, Institut Convergence Plascan, LYriCAN+, Centre de Recherche en Cancérologie de Lyon, France - INSERM U1052-CNRS UMR5286, France - University Claude Bernard Lyon , France
    073 | Revisiting the role of mitochondria during melanoma metastasis
    topicTopic: Metastasis and invasion
    person_pin
    Clara GIL - Centre de recherche en cancérologie de Lyon (CRCL), France
    074 | Oncogenic synergy between BMP and H3.3K27M mutation drives invasion in pediatric diffuse midline gliomas
    topicTopic: Metastasis and invasion
    person_pin
    Maud HAMADOU - CRCL, France
    075 | REACTIVATING BASP1 IN COLORECTAL CANCER CELLS SUPPRESSES MYC AND CLONOGENICITY BUT PROMOTES INVASIVE GROWTH
    topicTopic: Metastasis and invasion
    person_pin
    Markus HARTL - University of Innsbruck, Austria
    076 | THE UNDERLYING MOLECULAR MECHANISM OF TUMOUR BUDDING AND ITS RELATIONSHIP WITH TUMOUR MICROENVIRONMENT
    topicTopic: Metastasis and invasion
    person_pin
    Jean QUINN - Biomedical Science program, Faculty of Medicine Siriraj Hospital, Thailand
    077 | Deciphering the functionnal role of ribosomal RNAs’ 2’O-ribose methylation in breast cancer progression
    topicTopic: Metastasis and invasion
    person_pin
    Jordan HEDJAM - Cancer Research Centre of Lyon (CRCL) , France
    078 | Development of a new technology to study protein interactome in fixed cells and fixed tissue: application for the glucocorticoid receptor in breast cancer
    topicTopic: Metastasis and invasion
    person_pin
    Julien JACQUEMETTON - Cancer Research Center of Lyon (CRCL), Université de Lyon, Inserm U1052, CNRS UMR5286, France
    079 | SLX4 AND XPF IN CANCER AND CANCER TREATMENTS
    topicTopic: Metastasis and invasion
    person_pin
    Lars Petter JORDHEIM - CRCL, France
    080 | THE INFLAMMASOME PROTEIN NLRP3 INTERACTS WITH REV7 TO MAINTAIN GENOME INTEGRITY THROUGH HOMOLOGOUS RECOMBINATION INITIATION
    topicTopic: Metastasis and invasion
    person_pin
    Md Muntaz KHAN - CRCL, INSERM U1052, CNRS UMR5286, France - Université de Lyon, Université Claude Bernard Lyon 1, France - Centre Léon Bérard, France
    081 | Minimally Invasive Ablation, Cement, and Screw Fixation of Periacetabular Metastases Demonstrates Long-Term Improvement of Pain and Functional Outcomes: A Prospective Cohort Study
    topicTopic: Metastasis and invasion
    person_pin
    Francis LEE - Yale University, United States
    082 | Presence of Metastatic Breast Cancer Induces Gene Expression Changes at the Pathological Fracture Microenvironment
    topicTopic: Metastasis and invasion
    person_pin
    Francis LEE - Yale University, United States
    083 | Targeting PRMTs creates vulnerability of DNA double-stand break repair pathways, and potentiates chemotherapy efficacy in TNBC
    topicTopic: Metastasis and invasion
    person_pin
    Sebastien MARTINEZ - Centre de Recherche en Cancérologie de Lyon, France - Centre Leon Bérard, Oncology Department, France - Université Claude Bernard, France
    084 | Combining Narrative Medical Reports and Rough Path Theory for Survival Prediction: A Cox Model Approach with OncoBERT Embeddings
    topicTopic: Metastasis and invasion
    person_pin
    Paul MINCHELLA - Centre Léon Bérard, France
    085 | Predicting patients early discontinuation in early phase oncology clinical trials using Language Models
    topicTopic: Metastasis and invasion
    person_pin
    Louise OLGIATI - CRCL, Centre Léon Bérard, France
    086 | REGULATORY NETWORK INFERENCE OF DRUG-TOLERANT PERSISTER CELLS
    topicTopic: Metastasis and invasion
    person_pin
    Camille LÉONCE - CASTING - Cancer dynamics, adaptation and modeling, Inria, Inserm, Ecole Normale Supérieure de Lyon, Centre Léon Bérard, Cnrs, Université Claude Bernard Lyon 1., France - Univ Lyon, Claude Bernard Lyon 1 University, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France., France
    087 | Cell viscosity influences hematogenous dissemination and metastatic extravasation of tumor cells.
    topicTopic: Metastasis and invasion
    person_pin
    Naël OSMANI - Tumor Biomechanics lab, INSERM U1109 / CRBS, France
    088 | Role of cIAP1 in the TGF-β signaling pathway
    topicTopic: Metastasis and invasion
    person_pin
    Manon PACCAGNINI - HSP-Pathies Team, CTM UMR1231 Inserm/University of Burgundy, France
    089 | TARGETING NETRIN-1: A PROMISING RADIOTHERAPY WITH LU-177 COUPLED WITH NP137 FOR CHROMOPHOBE RENAL CELL CARCINOMA
    topicTopic: Metastasis and invasion
    person_pin
    Elisa PICCIONI - CRCL, France - Université Claude Bernard Lyon 1, France
    090 | Involvement of PRMT5 in Glucocorticoid Receptor signaling in Doxorubicin Resistance in Triple Negative Breast Cancer
    topicTopic: Metastasis and invasion
    person_pin
    Ludivine PRUVOST - Cancer Research Center of Lyon (CRCL), Université de Lyon, Inserm U1052, CNRS UMR5286, France
    091 | Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.
    topicTopic: Metastasis and invasion
    person_pin
    Margherita PUPPO - Universite de Lyon 1 (UCBL), France - INSERM, Research Unit UMR_S1033, LyOS, France
    092 | SNORD104-INDUCED RIBOSOMAL RNA 2’OME CONTRIBUTES TO CRIZOTINIB RESISTANCE IN ALK-TRANSLOCATED LUNG CANCER
    topicTopic: Metastasis and invasion
    person_pin
    Julie RADERMECKER - CRCL, France
    093 | THE ROLE OF THE TGF BETA SUPERFAMILY IN COLORECTAL CANCER DEVELOPMENT AND PROGRESSION
    topicTopic: Metastasis and invasion
    person_pin
    Natthamon SONTHI - Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom - Wolfson Wohl Cancer Research Centre, School of Cancer Sciences,College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom - Chulabhorn Royal Academy, Thailand
    094 | Lipid droplet dynamics in cancer - a metabolic link to cell death regulation
    topicTopic: Metastasis and invasion
    person_pin
    Kinga STOPA - Centre Léon Bérard - CRCL U1052, CNRS 5286, France - Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université Claude Bernard Lyon 1, France
    095 | The transcription factor Sox11 plays an essential role in TGF-β1-induced partial EMT and collective invasion in oncogenically transformed mouse intestinal organoids.
    topicTopic: Metastasis and invasion
    person_pin
    Yu-Hsiang TENG - Institute of Molecular Medicine and Cell Research, University of Freiburg, Germany - Faculty of Biology, University of Freiburg, Germany
    096 | CITED2 PROMOTES SELF-RENEWAL AND REDUCED INVASION IN GLIOBLASTOMA 3D MODELS
    topicTopic: Metastasis and invasion
    person_pin
    Mónica TEOTÓNIO FERNANDES - Algarve Biomedical Center Research Institute (ABC-RI), University of Algarve (UAlg), Portugal - School of Health (ESS), University of Algarve (UAlg), Portugal
    097 | Unravelling a new ECM remodeling function of the axon guidance molecule Netrin-1.
    topicTopic: Metastasis and invasion
    person_pin
    Gaetan THIVOLLE LIOUX - CRCL, France
    098 | Exogeneous loading of Extracellular Vesicles with Anti-Tumoral miRNAs as a Promising Approach for miRNA-Based Cancer Therapy
    topicTopic: Metastasis and invasion
    person_pin
    Guénolé TOSSOU - Immunologie humaine, physiopathologie immunothérapie – Institut National de la Santé et de la Recherche Médicale - INSERM, Université Paris Cité, France
    099 | A Prospective Evaluation of Automatic Trial Match Tools in a Molecular Tumor Board
    topicTopic: Metastasis and invasion
    person_pin
    Loic VERLINGUE - CLB, France
    100 | The anti-apoptotic protein Nrh inhibits apoptosis by altering the cellular localization of the pro-apoptotic Bax.
    topicTopic: Metastasis and invasion
    person_pin
    Esteban VIEUXMAIRE - Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL) INSERM, U1052, Cancer Research Center of Lyon (CRCL), Université de Lyon (UCBL1), CNRS UMR_5286, Centre Léon Bérard, Lyon, France, Cancer Cell Death Laboratory 28, rue Laennec - 69373 , France
    103 | Role of the BMP4/BMPR1A/BRCA1 axis in mammary stem cell transformation and basal-like breast cancer
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Simon AHO - Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, U1052 UMR5286, France
    104 | Variability of mutational signatures is a footprint of carcinogens
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Nicolas ALCALA - IARC - WHO, France
    105 | GENETIC VARIATION IN THE NUCLEAR FACTOR KAPPA B (NF-κB) AND THE RISK FOR COLORECTAL CANCER
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Maryam ALRASHID - Kuwait University, Kuwait
    106 | INVESTIGATING THE ASSOCIATION OF SELECTED SOD2 VARIANT AND NON-HODGKIN LYMPHOMA AMONG THE KUWAITI POPULATION.
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Raghad ALREFAII - Kuwait university, Kuwait
    107 | SOMATIC EVOLUTIONARY DYNAMICS AND ONCOGENESIS IN THE ORAL MUCOSA
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Charlotte ANDRIEU - INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, France - CREEC/UMR CNRS 5290-IRD 224-Université de Montpellier, France
    108 | STUDY OF THE MECHANISMS OF OCCURENCE AND EVOLUTION OF EARLY EPITHELIAL TUMOR. IMPLICATIONS FOR PROSTATE CARCINOGENESIS.
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Elissa BAABDATY - IGreD, France
    109 | Exposure to pesticides lead to alteration of pediatric bone marrow niche, with combined loss of intrinsic mesenchymal and hematopoietic stem cell properties.
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Anaëlle BOBARD - Cancer Research Center of Lyon, France - CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, , France - Inserm U1052, Centre de Recherche en Cancérologie de Lyon, , France - Université Claude Bernard Lyon 1, CRCL, France
    110 | Characterization of FSTL5 role in medulloblastoma and retina development
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Benjamin BONNEAU - Institut Curie, France
    111 | The feedforward loop between tryptophan and AHR in regulating cell identity and neoplastic transformation: a new target of endocrine-disrupting compounds.
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Clara CAMPRUBI - INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, France
    112 | THE ROLE OF DIPHENYL PHOSPHATE IN AHR SIGNALING AND BREAST CANCER RISK: IMPACT ON CELL IDENTITY AND TUMOR DEVELOPMENT IN TRIPLE-NEGATIVE BREAST CANCER MOUSE MODELS
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Samia SELMI-RUBY - Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS 5286, Centre Léon Bérard , France
    113 | Study of the oncogenic functions of NFATC2 gene fusions in sarcomas
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Pierre Elian CHAGHOURI - Inserm U1312 BRIC (BoRdeaux Institute of onCology), France - University of Bordeaux, France
    114 | SENESCENCE IS IMPORTANT FOR MAMMARY GLAND INVOLUTION AND POSTPARTUM BREAST CANCER
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Aurélie CHICHE - Institut Pasteur, France
    115 | Genomic integrity is largely maintained following precision genome editing in primary human hematopoietic stem and progenitor cells
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Fanny-Meï CLOAREC-UNG - Institut de Recherche en Immunologie et Cancérologie - Université de Montréal, Canada
    116 | Crispr screen to identify miRNAs potentially associated with oral cancer and the tumorigenic potential of sphingosine kinase 2
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Gabriel DA SILVA - School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Brazil
    117 | STX-1, A POTENT FIRST-IN-CLASS ADC TARGETING DPP4 AS A BIOMARKER OF SENESCENT TUMOR CELLS
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Delphine DAYDE - Starkage Therapeutics, France
    118 | EARLY MAMMARY ONCOGENIC STRESS ELICITS UPR-DRIVEN IMMUNOGENICITY SENSED BY NEUTROPHILS
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Antoine DEBIESSE - Centre de Recherche en Cancérologie de Lyon (CRCL), Centre Léon Bérard, Université de Lyon, France
    119 | Understanding KREMEN1-Induced Cell Death Interplays: Role of SEC24C and ATG9A
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Shiva GHASEMI FIROUZABADI - CRCL, cancer research center of lyon, France
    120 | Cell fate switch from stress-induced senescence to malignant progression by RSK3 kinase
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Anda HUNA - Cancer Research Center of Lyon, Inserm U1052, CNRS UMR 5286, Université de Lyon, Centre Léon Bérard, 69373 Lyon, France, France - Equipe Labellisée La Ligue Contre Le Cancer, Lyon, France, France
    121 | An aptamer-based strategy to specifically correct aberrant DNA methylation in non-small-cell lung cancer
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Maria IBBA - Institute of Experimental Endocrinology and Oncology “Gaetano Salvatore” (IEOS), National Research Council (CNR), Italy - Department of Precision Medicine, University of Campania “Luigi Vanvitelli”,, Italy
    122 | OGT and c-Myc promote non-canonical activation of gene expression by EZH2 in hepatocellular carcinoma
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Coline KERBAJ - Cancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte CLB, Université Lyon 1 (UCBL1), France - Institut Hospitalo-Universitaire EVEREST, France
    123 | The role of Follistatin-like protein 5 (FSTL5) in retinal development and medulloblastoma
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Valentina LO RE - Institut curie, France
    124 | THE GENETIC ARCHITECTURE OF THE HALLMARKS OF CANCER AND ITS ACQUISITION BY NORMAL TISSUES
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Laurane MANGÉ - Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, France
    125 | DOWNREGULATION OF ELN EXPRESSION TRIGGERS CELLULAR SENESCENCE THROUGH A MITOCHONDRIAL ROS/NRF2/HMOX1/IRON ACCUMULATION PATHWAY
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Nadine MARTIN - Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, Lyon, France, France - Equipe Labellisée la Ligue Contre le Cancer, Lyon, France, France
    126 | Design and generation of custom libraries for coordinated gene engineering and lineage-barcode tagging
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Jamie BEAULIEU - Institut de recherche en immunologie et en cancérologie de l’Université de Montréal, Canada
    127 | The Franco-Canadian Organoid Network: Standardizing 3D Cancer Models
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Sonya NASSARI - Spheroids, Tumoroids, Organoids and Microfluidics (STOrM) hub, Université de Sherbrooke, Canada
    128 | STUDYING THE IMPACT OF 11P15 LOSS OF HETEROZYGOSITY IN ONCOGENESIS
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Léana PERIGNON - Bordeaux Institute in Oncology - BRIC - BioGo team - Univ. Bordeaux - INSERM U1312, France
    129 | DEVELOPMENT OF A LOW BARRIER-TO-ENTRY MICROFLUIDIC CHIP FOR HIGH THROUGHPUT CLONAL CULTURES
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Eve PETIT - Insitut de Recherche en Immunologie et Cancérologie, Université de Montréal, Canada
    130 | THE ROLE OF THE GLUTAMYLASE TTLL6 IN COLON HOMEOSTASIS AND PATHOLOGY
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Vanessa PIRES - Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS, France
    131 | The nucleocytoplasmic transport of PRMT5 in luminal breast cancers plays an important role in the response to anti-estrogens
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Jennifer RAISCH - Institut de Recherche sur le Cancer de l’Université de Sherbrooke, Canada
    132 | Deciphering early immune surveillance mechanisms of preneoplastic cells by Natural Killer cells
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Lara REVOL-BAUZ - CISTAR team, Cancer Research Center of Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard, F-69000 Lyon, France, France
    133 | FACT complex as a critical regulator of growth and progression in oral squamous cell carcinoma
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Graziella RIBEIRO DE SOUSA - Dept Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Brazil, Brazil
    134 | DECIPHER THE ROLE OF DENDRITIC CELLS IN EARLY IMMUNE SURVEILLANCE DURING BREAST CANCER DEVELOPMENT
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Martial SCAVINO - UMR Inserm 1052 CNRS 5286, Cancer Research Center of Lyon, France
    135 | EVALUATION OF CANCER ADAPTIVE THERAPY IN PRE-CLINICAL MODELS
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Mohamad SKAYNI - Institute of Molecular Genetics of Montpellier, France
    136 | MET EXON 14 SKIPPING RECORDED IN LUNG CANCER HIGHLIGHTS INVOLVEMENT OF THE DEPENDANCE RECEPTORS PARADIGM IN TUMORIGENESIS
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Rémi TELLIER - Univ Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277, CANTHER – Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille; France, France
    137 | Pancreatic Cancer Stem Cells Expand Tumor Burden and Educate Tumor Adjacent Normal Acinar Cells to Initiate Carcinogenesis Dependent of the KRAS/CD106/NK-κB Positive Feedback Loop
    topicTopic: Preneoplasia and cancer initiation
    person_pin
    Zhichong WU - General Surgery Department and Pancreatic Disease Diagnosis and Treatment Center of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China - Research Institution of Pancreatic Diseases, Shanghai Jiao Tong University, School of Medicine, China - State Key Laboratory of Oncogenes and Related Genes, China - National Translational Medicine Center, China
    140 | Bio-molecular Fe(III) and Zn(II) Complexes Modulate PI3K/AKT1/EGFR Inhibition, Triggering Autophagy and Apoptosis in Epidermal Skin Cancer Cells.
    topicTopic: Immunology and immunotherapy
    person_pin
    Mohammad ALFAIFI - King Khalid University, Saudi Arabia
    141 | NF-kB2: A Key Regulator of CD8+ T Cell Anti-Tumor Activity
    topicTopic: Immunology and immunotherapy
    person_pin
    Khaled BOUHERROU - CRCL - INSERM U1052, France
    142 | IDENTIFICATION OF A NEW TARGET ON TUMOR-ASSOCIATED TREG INVOLVED IN THE INHIBITION OF MEMORY CD8 T CELL FUNCTIONS
    topicTopic: Immunology and immunotherapy
    person_pin
    Justine CINIER - Centre de Recherche en Cancérologie de Lyon, France
    143 | AN INTRAVENOUS INNATE IMMUNOSTIMULANT DISPLAYS POTENT ANTI-TUMOR ACTIVITY AGAINST METASTATIC AND DISSEMINATED TUMORS.
    topicTopic: Immunology and immunotherapy
    person_pin
    Anaïs DEBESSET - HEPHAISTOS-pharma, France
    144 | INNOVATIVE IMMUNOTHERAPIES BASED ON RADIOFREQUENCY AND IMMUNOGEL FOR LOCAL IMMUNE RESPONSE ACTIVATION IN COLORECTAL CANCER.
    topicTopic: Immunology and immunotherapy
    person_pin
    Sarah DIAKHABY - Université Paris Cité, CNRS, INSERM, UTCBS, France
    145 | Spatial mapping of the immune landscape in neuroblastoma and its relevance to disease outcome
    topicTopic: Immunology and immunotherapy
    person_pin
    Alexia GAZEU - Cancer Research Center of Lyon, Centre Léon Bérard, Université Claude Bernard Lyon 1, France - Multisite Institute of Pathology, Groupement Hospitalier Est, Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, France
    146 | Study of immuno-evasion and impact of lymph nodes on the therapeutic response to immune checkpoint inhibitors on an original 3D lymph node/tumoroid coculture model in lung cancer
    topicTopic: Immunology and immunotherapy
    person_pin
    Mallah HAMZA - Regenerative NanoMedicine, Centre de Recherche en Biomédecine de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), UMR_S U1260 INSERM and University of Strasbourg, France, France
    147 | NEUTROPHILS PROMOTE AGE-INDUCED METASTASIS
    topicTopic: Immunology and immunotherapy
    person_pin
    Cristina LIBONI - Tumor Biomechanics Lab, France - INSERM UMR_S1109, France - Université de Strasbourg, France - Fédération de Médecine Translationnelle de Strasbourg (FMTS), France - Equipe Labellisée Ligue Contre le Cancer, France
    148 | Circulating Levels of PD1 and TIM3 Predict Early Recurrence of Hepatocellular Carcinoma Following Percutaneous Thermal Ablation
    topicTopic: Immunology and immunotherapy
    person_pin
    Zuzana MACEK JILKOVA - Univ. Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Institute for Advanced Biosciences, France - Department of Hepatology and gastrointestinal medical oncology, Grenoble-Alpes University Hospital, France
    149 | Engineering safe anti-CD19-CD28ζ CAR T cells with CD8α hinge domain in serum-free media for adoptive immunotherapy
    topicTopic: Immunology and immunotherapy
    person_pin
    Sunil MARTIN - BRIC-Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, , India
    150 | Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing
    topicTopic: Immunology and immunotherapy
    person_pin
    Emilie NARNI-MANCINELLI - 1Aix Marseille Université, Centre National de la Recherche Scientifique, INSERM, Centre d'Immunologie de Marseille-Luminy, France
    151 | Early Immunoparalysis in Patients undergoing Pancreaticoduodenectomy - An Exploratory Study based on mHLA-DR expression
    topicTopic: Immunology and immunotherapy
    person_pin
    Rithya OU - Croix-Rousse University Hospital, Department of General Surgery and Liver Transplantation, France
    152 | AUTOMATIC TRANSLATION OF MEDICAL REPORTS IN ONCOLOGY IN ENGLISH BY AND FOR LANGUAGE MODELS
    topicTopic: Immunology and immunotherapy
    person_pin
    Julien PANEL - university Lyon-est rockfeller and Leon Berrard center , France
    153 | canSERV – providing cutting edge cancer research services across Europe
    topicTopic: Immunology and immunotherapy
    person_pin
    Jens K. HABERMANN - BBMRI-ERIC, Austria
    154 |
    The Growing Role of Immunotherapy in the Management of Hematologic Oncology Patients: A Five-Year Analysis (2020-2024)
    topicTopic: Immunology and immunotherapy
    person_pin
    Rachida SEDDIK - medipole de savoie, France
    155 | NEW MULTIFUNCTIONAL HYBRIDS AS MODULATORS OF
    APOPTOSIS MARKERS AND TOPOISOMERASE II IN BREAST
    CANCER THERAPY: SYNTHESIS, CHARACTERIZATION, AND IN VITRO AND IN SILICO STUDIES
    topicTopic: Immunology and immunotherapy
    person_pin
    M ER-RAJY - KING KHALID UNIVERSITY , Saudi Arabia
    156 | FROM 3D BIOPRINTED MODELS TO IN-VIVO PROOF OF CONCEPT : REPROGRAMMING OF TUMOR CELLS INTO ANTIGEN-PRESENTING CELLS AS A NEW IMMUNOTHERAPY STRATEGY
    topicTopic: Immunology and immunotherapy
    person_pin
    Marie TAUTOU - ANTINEO SAS, France
    157 | Humanized Avian Xenograft Models IMMUNO-AVI-PDX™ and IMMUNO-AVI-cellDX™: Accelerating Preclinical Immunotherapy and immune cell therapy Evaluation with Enhanced Predictive Accuracy
    topicTopic: Immunology and immunotherapy
    person_pin
    Marjorie LACOURREGE - ONCOFACTORY (ERBC), France
    158 | MEK inhibition in Cancer of Unknown Primary promotes cancer stem cell differentiation and restores tumor immunogenicity by increasing interferons response and decreasing PD-L1 expression
    topicTopic: Immunology and immunotherapy
    person_pin
    Federica VERGINELLI - Candiolo Cancer Institute, FPO-IRCCS, Cancer Stem Cell Laboratory, Italy
  • Registration & Information
    INSIGHT OUTSIDE
    26 av Jean Kuntzmann
    38330 Montbonnot - France
    Tel : +33 825 595 525 (0,15€/min*)
    Information desk: Monday to Friday
    From 9:00 to 12:00 and 14:00 to 17:00
    Organization
    Centre de recherche en cancérologie de Lyon (CRCL)
    UMR Inserm 1052 CNRS 5286 Mixte CLB
    Centre Léon Bérard Cheney D  - 2e étage
    28 rue Laennec
    69373 Lyon Cedex 08 - France 
    Pierre Chaumont
    (*) Prices starting from fixed line incumbent, a surcharge may be applied by operators, counting the second after the first 45 seconds.

    According to France's Personal Data Privacy Act in effect since June 2004, you may send a request in writing to INSIGHT OUTSIDE - 26 avenue Jean Kuntzmann - 38330 Montbonnot / France, or by email webmaster@insight-outside.fr to access your file in order to consult, modify and/or delete your personal information.

    © 2005 - 2025 Insight Outside